Purchase Order 75F40121P00404
- Not listed
- The Department of Health and Human Services' Food and Drug Administration awarded a $611,141 firm fixed price definitive contract to Clarivate Analytics (Us) LLC for a Cortellis Clinical Trials software license. Under this contract, Clarivate Analytics will provide its Cortellis Clinical Trials software to support the FDA's clinical research programs. No major subcontractors or set aside designations were identified. The Cortellis Clinical Trials software will be licensed for use at the FDA's...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Clarivate Cortellis Pharmaceutical Database subscription. The potential value of this award is $29,806.14 and the performance period runs through September 18, 2023. Clarivate Analytics provides scientific literature database subscriptions and analytics platforms to various federal agencies,...
- The U.S. Food and Drug Administration (FDA) awarded a $663,167.34 firm fixed-price purchase order to Clarivate Analytics (Us) LLC for a library subscription to Web of Science, Citation Connection, and InCites. The contract has an ultimate completion date of December 31, 2019 and was awarded on December 30, 2016. Clarivate Analytics (Us) LLC is a global leader in providing scientific, technical, medical, and scholarly research tools and services to federal agencies. This purchase order is not...
- The Food and Drug Administration awarded a purchase order to American Chemical Society for SciFinder subscription services valued at $2,417,270 on May 6, 2020, with an ultimate completion date of September 29, 2025. Performance occurs at Takoma Park, Maryland. The order provides a one-year site license for unlimited access to the SciFinder discovery platform and chemical databases, with four one-year option periods. Pricing is firm fixed-price. The solicitation (RFQ1224358), posted February...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and technical information and analytics services. The contract, valued at $188,500.00, is for the acquisition of Active Pharmaceutical Ingredients (API) manufacturer data. The contract is a firm fixed price Purchase Order with no set-aside designation. Clarivate Analytics is a prime contractor that has...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for annual site licenses to the Web of Science and Web of Knowledge scientific databases. The contract has a ceiling value of $342,101.00 and a completion date of December 31, 2016. No set-aside designation was used. Clarivate Analytics is a global leader in providing scientific, technical, medical, and scholarly research databases,...
- This is a non-competitive contract award by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Clarivate Analytics (US) LLC for Clarivate's "Drug Research Advisor" and "Key Pathway Advisor" software tools. The contract is a firm fixed-price purchase order with a ceiling value of $40,117.55. The contract was awarded without any set-aside designation as Clarivate was determined to be the sole source provider...
- This is a $39,540.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization. The contract is for a digital subscription to the Web of Science citation connection service. The contract does not have a set-aside designation. Clarivate Analytics (Us) LLC is a global leader in providing scientific, technical, medical, and scholarly research databases, analytics platforms, and information...
- The Internal Revenue Service awarded a $21,475.17 firm fixed-price purchase order to Clarivate Analytics (US) LLC on September 27, 2021, for subscription access to the Clarivate Analytics Cortellis Deals Intelligence Database. The one-year contract period extended from September 27, 2021, through September 26, 2022, with no set-aside designation applied. Clarivate Analytics, a foreign-owned global provider of scientific, technical, medical, and scholarly research databases, delivers this...
The Food and Drug Administration awarded a purchase order to Clarivate Analytics (US) LLC on September 3, 2021, with a ceiling value of $2,317,533.57 for biomarker database search solutions supporting drug development qualification at the Center for Drug Evaluation and Research. Work is performed at Takoma Park, Maryland and the FDA. The contract provides five-year, ten-user license access to a curated biomarker database with search and analytical functions enabling evaluation of biomarker drug development tool submissions. The ultimate completion date is March 6, 2026. The solicitation (posted August 26, 2021; quotes due September 2, 2021) sought the most technically acceptable solution at the lowest price under NAICS 541715 and PSC D302 on a firm fixed-price basis with no set-aside. SCI-reported invoiced revenue totaled $676 thousand in FY2022, $434 thousand in FY2023, and $434 thousand in FY2024. The awardee self-performed all reported hours with no subcontractors.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Biomarker Database Search Solutions | FDA-21-RFQ-1247113 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 2/2 | 9/3/21, 3:37 PM | |
Biomarker Database Search Solutions | FDA-21-RFQ-1247113 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/2 | 8/26/21, 2:17 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $433.8k | 2/16/23 | |
| P00002 | Exercise an Option | $408.9k | 2/14/22 | |
| P00001 | Other Administrative Action | $0 | 11/19/21 | |
| Not listed | Not listed | $267.2k | 9/2/21 |